Cybin (HELP) Gains from Investment Securities (2021 - 2022)
Cybin (HELP) reported Gains from Investment Securities of -$16101.7 for Q3 2022, down 103.18% on a YoY basis from $506038.7 in Q3 2021, and down 102.92% quarter-over-quarter from $551368.6 in Q4 2021.
Cybin (HELP) Gains from Investment Securities (2021 - 2022) Analysis & Trends
Cybin has reported Gains from Investment Securities for 2 years, with the latest figure at -$16101.7 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -16,101.67 |
| Sep 30, 2022 | -16,101.67 |
| Dec 31, 2021 | 551,368.58 |
| Dec 31, 2021 | 551,368.58 |
| Sep 30, 2021 | 506,038.73 |
| Sep 30, 2021 | 506,038.73 |
| Jun 30, 2021 | -497,878.62 |
| Jun 30, 2021 | -497,878.62 |